FDA ‘evaluating regulatory action’ over link between GLP-1 receptor agonists and suicidal thoughts The US Food and Drug Administration said it had received reports of suicidal ideation in patients taking GLP-1 receptor agonists through its adverse events reporting system.…
Non-hormonal treatment for menopause vasomotor symptoms approved for use in the UK Fezolinetant is an alternative to hormone replacement therapy for people experiencing vasomotor symptoms of menopause.…
Smoking cessation medicine cytisine to be available in January 2024, distributor confirms Exclusive: Cytisine was approved for use in the UK by the Medicines and Healthcare products Regulatory Agency in March 2019, but no supplies have been previously available.…
Coroner advises NHS England to warn prescribers about interaction of tramadol and warfarin The coroner’s report says NHS England’s response “must contain details of action taken or proposed to be taken, setting out the timetable for action” or must explain why no action is proposed.…
MHRA will take a ‘more proactive approach’ to reclassification, says chief executive June Raine told delegates at an event held on 12 December 2023 that a 5% reduction in medicine prescribing through reclassification could save the NHS £1.4bn each year.…
New valproate prescriptions must be signed off by two specialist doctors from January 2024, says MHRA The requirement for valproate prescriptions, which will come into effect on 31 January 2024, was first announced in December 2022.…
MHRA warns of dangers of fake weight loss pens after Yellow Card reports The medicines regulator said Ozempic and Saxenda pens have been confirmed as being falsified with insulin in five of the reports.…
Tirzepatide approved for weight loss treatment by regulator The Medicines and Healthcare products Regulatory Agency has said tirzepatide will be available to patients with obesity, or who are overweight, with weight-related health problems.…
Medicines regulator approves anastrozole for prevention of breast cancer in post-menopausal women NHS England says around 289,000 women at moderate or high risk of breast cancer could benefit from anastrozole.…
MHRA seizes £5m of illegally-traded medicines in 15th year of medicines crime initiative Interpol says the haul from this year's Operation Pangea posed a “significant threat to consumer safety”.…
